Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. Oct 26, 2021; 9(30): 9134-9143
Published online Oct 26, 2021. doi: 10.12998/wjcc.v9.i30.9134
Figure 1
Figure 1 Changes in lung lesions after nab-paclitaxel plus apatinib treatment. A: Computed tomography (CT) before treatment (baseline); B: CT scans after 6 cycles of nab-paclitaxel plus apatinib.
Figure 2
Figure 2 Needle biopsy of lung metastasis. A: Hematoxylin and eosin stain of tissue with tubular structures, and cells that are not significantly heteromorphic (original magnification × 200); B: Immunohistochemical staining of CK19 was strongly positive on tumor-cell membranes (original magnification × 200); C: Immunohistochemical staining of CA19-9 was strongly positive in tumor-cell cytoplasm (original magnification × 200).
Figure 3
Figure 3 Timeline of interventions and outcomes. bTMB: Blood tumor mutational burden; CA19-9: Carbohydrate antigen 19-9; CT: Computed tomography; COVID-19: Coronavirus disease 2019; PD: Progressive disease; PR: Partial response.